Polypharmacy Among Inpatients of a University Psychiatry Clinic: A Retrospective Study

被引:5
作者
Yenilmez, Cinar [1 ]
Gulec, Gulcan [1 ]
Buyukkinaci, Alev [2 ]
Dayi, Ali [1 ]
HulyaTurgut [1 ]
Uludag, Yasemin Tekin [1 ]
Akbaba, Sevil [1 ]
机构
[1] Eskisehir Osmangazi Univ, Med Sch, Dept Psychiat, Eskisehir, Turkey
[2] Boylam Psychiat Hosp, Ankara, Turkey
关键词
Polypharmacy; inpatients; antipsychotic; antidepressant;
D O I
10.5350/DAJPN2012250105
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: It has been reported that polypharmacy was frequent and increased lately. In our study, our purpose was to define the prevalence of polypharmacy and the level of polypharmacy according to the specified diagnostic groups. Method: The files of 201 inpatients admitted between January 2010 and January 2011 were evaluated retrospectively. For every patient's last admission, prescribed drugs at that admission, time period of that admission, the number of past admissions and demographic data were evaluated and statistical analysis was performed. Results: In the evaluation of the last admissions of 201 inpatients, it was detected that 145 (72.1%) patients had been given polypharmacy at discharge. Polypharmacy was mostly used in psychotic patients (60%) and number of drugs used per patient was 2.2. Polypharmacy was significantly more frequent in patients living in cities, with a longer hospital stay and in patients with higher number of past admissions. Conclusion: Our finding of high percentage of polypharmacy shows that treatment algorithms are not followed as much as expected. With the development of the evidence based psychiatry, it is necessary to define ratios of benefits and harms while using polypharmacy. Only by this way, questions about if polypharmacy is a suitable approach or if the treatment algorithms can be changed accordingly may be answered.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 35 条
[1]   Antipsychotic Polypharmacy and Risk of Death From Natural Causes in Patients With Schizophrenia: A Population-Based Nested Case-Control Study [J].
Baandrup, Lone ;
Gasse, Christiane ;
Jensen, Vibeke D. ;
Glenthoj, Birte Y. ;
Nordentoft, Merete ;
Lublin, Henrik ;
Fink-Jensen, Anders ;
Lindhardt, Anne ;
Mortensen, Preben B. .
JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (02) :103-108
[2]  
Baranzini Federico, 2009, Recenti Progressi in Medicina, V100, P9
[3]  
BOKE O, 2006, KLIN PSIKOFARMAKOL B, V16, P167
[4]  
Brazeau S., 2001, CAN J CME AUG, P85
[5]   Prescribing patterns of antipsychotics in 13 French psychiatric hospitals [J].
Bret, P. ;
Bret, M. -C. ;
Queuille, E. .
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2009, 35 (02) :129-138
[6]   Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy [J].
Carnahan, RM ;
Lund, BC ;
Perry, PJ ;
Chrischilles, EA .
ACTA PSYCHIATRICA SCANDINAVICA, 2006, 113 (02) :135-141
[7]   Hospital use of antipsychotic drugs: polytherapy [J].
Centorrino, Franca ;
Cincotta, Stephanie L. ;
Talamo, Alessandra ;
Fogarty, Kate V. ;
Guzzetta, Francesca ;
Saadeh, Mark G. ;
Salvatore, Paola ;
Baldessarini, Ross J. .
COMPREHENSIVE PSYCHIATRY, 2008, 49 (01) :65-69
[8]  
Cerit C, 2010, PSYCHOPHARMACOL BULL, V43, P22
[9]   Does antipsychotic polypharmacy increase the risk for metabolic syndrome? [J].
Correll, Christoph U. ;
Frederickson, Anne M. ;
Kane, John M. ;
Manu, Peter .
SCHIZOPHRENIA RESEARCH, 2007, 89 (1-3) :91-100
[10]  
Dilbaz N, 2010, KLIN PSIKOFARMAKOL B, V20, pS4